Literature DB >> 212572

Isolation of two human tumor epithelial cell lines from solid breast carcinomas.

E Y Lasfargues, W G Coutinho, E S Redfield.   

Abstract

Most of the available human breast tumor cell lines have been derived from pleural effusions. The two cell lines herein described, BT-474 and BT-483, were derived from solid, invasive ductal breast carcinomas. Both are epithelial and neoplastic as judged by their general morphology, their fine structure, and their ability to produce growing nodules in nude mice and colonies in soft agar and methocel. BT-474 and BT-483 are human as expressed by chromosome morphology and aneuploid with a modal number of 55 and 72 chromosomes, respectively. Trypsin-Giemsa banding did not reveal the presence of obvious HeLa markers, and the glucose 6-phosphate dehydrogenase electrophoretic migration pattern was of the B-type. Furthermore, the migration of lactic dehydrogenase, malic dehydrogenase, and 6-phosphogluconate dehydrogenase isoenzymes was consistent with a human pattern and different from that of the mouse, rat, or hamster. Quarterly tests to detect the presence of aerobic and anaerobic mycoplasmas were repeatedly negative. A culture medium containing insulin, increased amounts of amino acids, vitamins, and glucose facilitated the isolation of the tumor cells. Cell replication was maintained with 10% fetal calf serum absorbed with activated charcoal and dextran. No production of alpha-lactalbumin was detected by radioimmunoassays, but high levels of progesterone receptors were found in both cell lines.

Entities:  

Mesh:

Year:  1978        PMID: 212572

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  71 in total

1.  A set of imprinted genes required for normal body growth also promotes growth of rhabdomyosarcoma cells.

Authors:  Geoffrey Rezvani; Julian C K Lui; Kevin M Barnes; Jeffrey Baron
Journal:  Pediatr Res       Date:  2012-01       Impact factor: 3.756

2.  A human breast tumor cell line (BT-474) that supports mouse mammary tumor virus replication.

Authors:  E Y Lasfargues; W G Coutinho; A S Dion
Journal:  In Vitro       Date:  1979-09

3.  Inferring alterations in cell-to-cell communication in HER2+ breast cancer using secretome profiling of three cell models.

Authors:  David J Klinke; Yogesh M Kulkarni; Yueting Wu; Christina Byrne-Hoffman
Journal:  Biotechnol Bioeng       Date:  2014-04-18       Impact factor: 4.530

4.  Investigations into the potential role of aberrant N-acetylgalactosamine glycans in tumour cell interactions with basement membrane components.

Authors:  Susan A Brooks; Debbie M S Hall
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

5.  Differential proteomic analysis of caveolin-1 KO cells reveals Sh2b3 and Clec12b as novel interaction partners of caveolin-1 and Capns1 as a potential mediator of caveolin-1-induced apoptosis.

Authors:  Yogesh M Kulkarni; Changxing Liu; Qi Qi; Yanmei Zhu; David J Klinke; Jun Liu
Journal:  Analyst       Date:  2013-11-21       Impact factor: 4.616

6.  Two new estrogen-supersensitive variants of the MCF-7 human breast cancer cell line.

Authors:  C Natoli; G Sica; V Natoli; A Serra; S Iacobelli
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

7.  Characterisation of breast cancer cell lines and establishment of a novel isogenic subclone to study migration, invasion and tumourigenicity.

Authors:  Linda Hughes; Catherine Malone; Saranya Chumsri; Angelika M Burger; Susan McDonnell
Journal:  Clin Exp Metastasis       Date:  2008-04-02       Impact factor: 5.150

8.  Development of a new human breast cancer cell line Ia-270.

Authors:  P M Loh; G Clamon; J MacIndoe; M White; L Urdaneta; B Hukku; W D Peterson
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

9.  Inferring predominant pathways in cellular models of breast cancer using limited sample proteomic profiling.

Authors:  Yogesh M Kulkarni; Vivian Suarez; David J Klinke
Journal:  BMC Cancer       Date:  2010-06-15       Impact factor: 4.430

Review 10.  Local control by radiotherapy: is that all there is?

Authors:  Silvia C Formenti; Sandra Demaria
Journal:  Breast Cancer Res       Date:  2008-11-05       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.